Cleveland Clinic Rheumatology
G

Taming the T-Cell and Prospects for CAR T-Cell Therapy

By Cleveland Clinic Rheumatology FEATURING Georg Schett
By Cleveland Clinic Rheumatology FEATURING Georg Schett
0 views
November 15, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

15:59
GSK

An Efficacy and Safety Review for Patients With Severe Eosinophilic …

Feat. Y. Goldman

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Recommended

AUTOPLAY
21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
57:03
University of Colorado Department of Medicine

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

Feat. E. Wallace, J. Zell
07:11
GRACE

CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologis…

Feat. A. Goodman, A. Jeong, S. Rajeeve
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
20:18
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Will Immune Therapy Replace Transplant in Hematologic Malignancies?

Feat. R. Gale
04:08
GRACE

CAR T-Cell Therapy Side Effects for Blood Cancers

Feat. A. Goodman
32:52
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

The Improbable History of CAR T-Cells

Feat. C. June
20:18
Stanford Medicine

Risk of Second Malignancies and T-Cell Lymphoma After CAR T-Cell The…

Feat. M. Hamilton
15:24
Michael Soulen

Interventional Delivery of CAR-T Therapy

28:10
Indy Hematology Review

2024 Updates on Understanding & Managing Immune Effector Cell To…

Feat. D. Reeves
46:03
University of Colorado Cancer Center

CAR NK Cells: Next Generation Cell Therapies for Cancer

Feat. K. Rezvani
28:07
Indy Hematology Review

Controversies and Recommendations for the Treatment of ALL and Lymph…

Feat. W. Stock
07:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Putting the CAR-T Before the Horse - Impr…

Feat. L. Shune
25:24
Beth Israel Deaconess Medical Center

CAR T-Cell Failure: Mechanisms and Salvage Options

Feat. J. Arnason
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
31:00
Louisville Hematology Highlights

Current Approaches in the Frontline Treatment of Adult ALL

Feat. N. Short
33:11
Total Health

Bispecific Antibodies and CAR T-Cells for NHL: Challenges and Opport…

Feat. K. Komanduri
24:12
SIR 2022 Coverage

New and Evolving Clinical Trials: Embolotherapy

Feat. M. Soulen
16:18
ImmunoTherapy Bridge 2023

Innovating Immunotherapy for Pancreatic Cancer

Feat. G. Lesinski